ID   NCC-MFS7-C1
AC   CVCL_E4BL
RX   PubMed=39214957;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 29 hours (PubMed=39214957).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=39214957).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Thoracic wall; UBERON=UBERON_0016403.
ST   Source(s): PubMed=39214957
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
RX   PubMed=39214957; DOI=10.1007/s13577-024-01124-4;
RA   Adachi Y., Noguchi R., Osaki J., Ono T., Iwata S., Akiyama T.,
RA   Tsuchiya R., Toda Y., Sekita T., Iwata S., Kobayashi E., Kojima N.,
RA   Yoshida A., Yokoo H., Kawai A., Kondo T.;
RT   "Establishment and characterization of two novel patient-derived cell
RT   lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1.";
RL   Hum. Cell 37:1742-1750(2024).
//